BME100 f2016:Group14 W8AM L3

From OpenWetWare

Jump to: navigation, search
BME 100 Fall 2016 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help
Image:BME494_Asu_logo.png


Contents

OUR TEAM

Name: Diego Barra
Name: Diego Barra
Name: Savanna Bracale
Name: Savanna Bracale
Name: Casin Corallo
Name: Casin Corallo
Name: Imelda Fragoza
Name: Imelda Fragoza
Name: Andrew Samanta
Name: Andrew Samanta

LAB 3 WRITE-UP

Descriptive Stats and Graph

Average Heart Rate
Average Heart Rate
Value Spree Band Pulse Ox
Number of Data 304 303
Mean 98.9 98.1
Standard Deviation 24.8 23.0


Average Temperature
Average Temperature
Value Spree Band Oral Thermometer
Number of Data 324 326
Mean 95.5 96.7
Standard Deviation 0.87 1.92



Inferential Stats

Heart Rate

p value (Paired)= 0.427; No Significant Difference

Pearson's r= 0.644; No Significant Difference


CONCLUSION: The Spree Band is accurate/precise for measuring heart rate.

Temperature

p value (Paired)= 1.100E-21; Yes Significant Difference

Pearson's r= 0.193; Yes Significant Difference


CONCLUSION: The Spree Band is NOT accurate/precise for measuring temperature.

Experimental Design of Own Device

Hypothesis: Using a patch to administer ADHD medication and using currents to control dosage will be more efficient than consuming pills because the patch will promote consistency in dosage and easier use, since it is on the skin all day and steadily releases medication. The current will be beneficial because it will be synced with an app and allow subjects to disperse more of a controlled dosage when needed.

Experiment: In order to test the prototype we will conduct two experiments. In the first experiment group one will test people recently diagnosed with ADHD and no previous usage of ADHD medication on the patch for 60 days. This would be done to avoid bias samples because people who have already taken a form of ADHD medication could potentially favor that form of medication. A physician certified to diagnose ADHD will survey them before the experiment, one check-up at the 30 day mark, and immediately after the 60 day trial. The physician’s survey of patients will include concentration based tests at each check up. The second experiment will test people who have taken Adderall pills for their ADHD. The sample size for both experiments will be a group of 100 patients. This group will help decipher which form of ADHD medication patients prefer. The testing will follow the format of the first group. The physician will test the subjects, before the experiment, after 30 days, and at the end of the 60 days.

Personal tools